Antibody-mediated neutralization in vivo of infectious papillomaviruses.
about
Pathobiology of papillomavirus-related cervical diseases: prospects for immunodiagnosis.Papillomavirus prophylactic vaccines: established successes, new approaches.The L1 major capsid protein of human papillomavirus type 16 variants affects yield of virus-like particles produced in an insect cell expression system.Human papillomavirus type 11 recombinant L1 capsomeres induce virus-neutralizing antibodies.Fowlpox virus recombinants expressing HPV-16 E6 and E7 oncogenes for the therapy of cervical carcinoma elicit humoral and cell-mediated responses in rabbits.Combination treatment with intralesional cidofovir and viral-DNA vaccination cures large cottontail rabbit papillomavirus-induced papillomas and reduces recurrences.Characterization of monoclonal antibodies specific for the Merkel cell polyomavirus capsidIn vitro infection and type-restricted antibody-mediated neutralization of authentic human papillomavirus type 16.In vivo mechanisms of vaccine-induced protection against HPV infection.Different heparan sulfate proteoglycans serve as cellular receptors for human papillomaviruses.Life cycle heterogeneity in animal models of human papillomavirus-associated diseasePlant-produced cottontail rabbit papillomavirus L1 protein protects against tumor challenge: a proof-of-concept study.High-throughput pseudovirion-based neutralization assay for analysis of natural and vaccine-induced antibodies against human papillomaviruses.How will HPV vaccines affect cervical cancer?Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection.Papillomavirus L1 capsids agglutinate mouse erythrocytes through a proteinaceous receptorImmunization with viruslike particles induces long-term protection of rabbits against challenge with cottontail rabbit papillomavirus.Assessment of the serological relatedness of genital human papillomaviruses by hemagglutination inhibition.In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotype.Characterization of a human papillomavirus type 16 variant-dependent neutralizing epitope.Coinfection of human foreskin fragments with multiple human papillomavirus types (HPV-11, -40, and -LVX82/MM7) produces regionally separate HPV infections within the same athymic mouse xenograft.Mother-infant transfer of anti-human papillomavirus (HPV) antibodies following vaccination with the quadrivalent HPV (type 6/11/16/18) virus-like particle vaccineCancer of the cervix: prospects for immunological controlProtection of rabbits against challenge with rabbit papillomaviruses by immunization with the N terminus of human papillomavirus type 16 minor capsid antigen L2.Detection of antibodies against human papillomavirus (HPV) type 16 virions by enzyme-linked immunosorbent assay using recombinant HPV 16 L1 capsids produced by recombinant baculovirus.Identification of a human papillomavirus type 16-specific epitope on the C-terminal arm of the major capsid protein L1Interaction of papillomaviruses with the cell surfaceNeutralization of bovine papillomavirus by antibodies to L1 and L2 capsid proteins.Cottontail rabbit papillomavirus L1 protein-based vaccines: protection is achieved only with a full-length, nondenatured productExpression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of viruslike particlesMonoclonal antibody-mediated neutralization of infectious human papillomavirus type 11Multiscale macromolecular simulation: role of evolving ensembles.New approaches to prophylactic human papillomavirus vaccines for cervical cancer preventionChimeric L1-L2 virus-like particles as potential broad-spectrum human papillomavirus vaccines.Xenograft model for identifying chemotherapeutic agents against papillomaviruses.Quantitative disassembly and reassembly of human papillomavirus type 11 viruslike particles in vitro.Two amino acid residues confer type specificity to a neutralizing, conformationally dependent epitope on human papillomavirus type 11.A cryo-electron microscopy study identifies the complete H16.V5 epitope and reveals global conformational changes initiated by binding of the neutralizing antibody fragmentEvolutionary and structural analyses of alpha-papillomavirus capsid proteins yields novel insights into L2 structure and interaction with L1.Induction of immune responses against human papillomaviruses by hypervariable epitope constructs.
P2860
Q30450185-F72EE613-1342-44FF-BEF7-753E5C4ABFB1Q33614425-53319E14-CFF5-47DE-BF20-38F0055BDD18Q33673620-7C7269D3-E545-45F2-AD10-3CB316755042Q33785841-417401B5-7560-4769-AA6B-BCFD7DB09A79Q33863923-7B92BB2F-5329-4139-9843-EB3361A1B501Q33981920-F23BD4FF-981A-4950-82F4-4597105077F8Q34036827-F14384E0-C268-4936-93E3-E5937136EEB1Q34069054-B91BA782-3993-4D67-AB56-03B6EE731C7FQ34125906-E93B186E-3C23-4626-B402-76CF639A5F2DQ34227402-69B23997-EA17-4AFF-A485-0E944831B031Q34348189-5AF03FFF-F738-4EB1-B204-5AAE58377569Q34975090-D77B55BB-54B1-43C0-8EC9-6A5A4AF2A4DDQ35016793-9521A9FC-C9DA-4A83-9BEC-420682325577Q35235035-A1712ABD-4C3D-4EFC-8147-F9793C815331Q35840539-862950AB-F39D-4BED-B29E-203E55F2FF66Q35845291-77A7921D-F12F-40AB-8C9F-C4E0AD94D762Q35854601-1F5F3ABA-96E2-4015-85A7-92DBD496AFE2Q35860748-D9173629-E2CB-459C-8FCF-25EB22D01120Q35867810-57F3FC3D-2AAE-4C9D-AF32-57858323D200Q35890718-1DFDCC13-6998-4488-B788-A9D3B74A7129Q35895217-6CE87910-A788-4D4B-A04D-30FF864C7214Q36017795-4D4A414D-1B5E-4B46-916D-D37614B1A931Q36029314-53174664-9FB3-4E46-B75A-E889A882BAEAQ36314993-CAFD10DF-315E-4054-BE65-A40A4E9FB13DQ36522299-0056DFD8-4F66-49C3-9B31-44A7643BC488Q36541188-BE5C5364-318B-48DA-B915-CF2DDFC87BBCQ36637073-4EDE2DEF-2D7F-4439-A19D-BD7B6348AC3AQ36637389-9CF51699-30B3-4B6B-A4D5-5733FC962052Q36650162-FADC4004-41A9-47F4-A856-8988725C015CQ36685977-30BB2EAC-76FA-4FA1-8E72-F1BC4110D2B1Q36793675-0E546948-BDBC-4374-B64E-0D31A5CF8E8BQ37042055-0529ADCC-D601-4A6F-92AC-F076C075E177Q37274559-5559B129-ABD1-485E-9096-40B1632D48B7Q37356046-A56AE73E-58CB-4555-A84D-50CDC00475A8Q39476798-C2B14F1D-1B00-47EA-95CA-031D05AC97DAQ39577044-CDFDA1D3-474B-4A92-B191-31D40105E0DDQ39875296-B44FF6AD-22FC-441C-A9D9-ADED482C89CBQ41606985-A2FA5CC9-758F-4053-A067-80EA20149419Q42785059-07507789-3474-455B-92EC-4FD4031CDB7BQ46353574-3101E2E9-06D8-4C55-AEA2-1DF6B2165BEB
P2860
Antibody-mediated neutralization in vivo of infectious papillomaviruses.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Antibody-mediated neutralization in vivo of infectious papillomaviruses.
@ast
Antibody-mediated neutralization in vivo of infectious papillomaviruses.
@en
type
label
Antibody-mediated neutralization in vivo of infectious papillomaviruses.
@ast
Antibody-mediated neutralization in vivo of infectious papillomaviruses.
@en
prefLabel
Antibody-mediated neutralization in vivo of infectious papillomaviruses.
@ast
Antibody-mediated neutralization in vivo of infectious papillomaviruses.
@en
P2860
P1433
P1476
Antibody-mediated neutralization in vivo of infectious papillomaviruses.
@en
P2093
J W Kreider
N D Christensen
P2860
P304
P407
P577
1990-07-01T00:00:00Z